HAVcR-1 reduces the integrity of human endothelial tight junctions

Anticancer Research

Volumn 31, Issue 2, 2011, Pages 467-473

  Martin, Tracey A ^a   Harrison, Gregory M ^a   Mason, Malcolm D ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Endothelial cells; HAVcR 1; Tight junction; Tight junction regulation

Indexed keywords

KIDNEY INJURY MOLECULE 1; PROTEIN ZO1; PROTEIN ZO2; RHO C PROTEIN; RHO FACTOR; SCATTER FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ELECTROPORATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; TIGHT JUNCTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; CELL MEMBRANE PERMEABILITY; ELECTROPORATION; ENDOTHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GENE KNOCKDOWN TECHNIQUES; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOPRECIPITATION; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; PHOSPHOPROTEINS; PLASMIDS; RECEPTORS, VIRUS; TIGHT JUNCTIONS;

EID: 79953249128     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kaplan G, Totsuka A, Thompson P, Akatsuka T, Moritsugu Y and Feinstone SM: Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus. EMBO J 15: 4282-4296, 1996. (Pubitemid 26278711)
2. Barton ES, Forrest JC, Connolly JL, Chappell JD, Liu Y, Schnell FJ, Nusrat A, Parkos CA and Dermody TS: Junction adhesion molecule is a receptor for reovirus. Cell 104: 441-451, 2001. (Pubitemid 32206464)
3. Ostermann G, Weber KS, Zernecke A, Schröder A and Weber C: JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 31: 51-58, 2002.
4. Ozaki H, Ishii K, Horiuchi H, Arai H, Kawamoto T, Okawa K, Iwamatsu A and Kita T: Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. J Immunol 163: 553-557, 1999. (Pubitemid 29328054)
5. Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT and Bergelson JM: The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci USA 98: 15191-15196, 2001. (Pubitemid 34013991)
6. Aoki J, Koike S, Asou H, Ise I, Suwa H, Tanaka T, Miyasaka M and Nomoto A: Mouse homolog of poliovirus receptor-related gene 2 product, mPRR2, mediates homophilic cell aggregation. Exp Cell Res 23: 374-384, 1997. (Pubitemid 27398396)
7. Warner MS, Geraghty RJ, Martinez WM, Montgomery RI, Whitbeck JC, Xu R, Eisenberg RJ, Cohen GH and Spear PG: A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and Pseudorabies virus. Virology 246: 179-189, 1998. (Pubitemid 28384071)
8. Kikyo M, Matozaki T, Kodama A, Kawabe H, Nakanishi H and Takai Y: Cell-cell adhesion-mediated tyrosine phosphorylation of nectin-2δ, an immunoglobulin-like cell adhesion molecule at adherens junctions. Oncogene 19: 4022-4028, 2000.
9. Tsukita S, Furuse M and Itoh M: Molecular dissection of tight junctions. Cell Struct Funct 21: 381-385, 1996.
10. Wittchen ES, Haskins J and Stevenson BR: Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J Biol Chem 274: 35179-35185, 1999. (Pubitemid 129509574)
11. Gopalakrishnan S, Raman N, Atkinson SJ and Marrs JA: Rho GTPase signaling regulates tight junction assembly and protects tight junctions during ATP depletion. Am J Physiol 275: C798-C809, 1998.
12. Martin TA, Watkins G, Mansel RE and Jiang WG: Hepatocyte growth factor disrupts tight junctions in human breast cancer cells. Cell Biol Int 28: 361-371, 2004. (Pubitemid 38748926)
13. Jiang WG, Martin TA, Matsumoto K, Nakamura T and Mansel RE: Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells. J Cell Physiol 181: 319-329, 1999. (Pubitemid 29463647)
14. Langbein L, Pape UF, Grand C, Kuhn C, Praetzel S, Moll I, Moll R and Franke WW: Tight junction-related structures in the absence of a lumen: occiudin, claudins and tight junction plaque proteins in densely packed cell formations of stratified epithelia and squamous cell carcinomas. Eur J Cell Biol 82: 385-400, 2003. (Pubitemid 37168660)
15. Wong V and Gumbiner BM:A synthetic peptide corresponding to the extracellular domain of occiudin perturbs the tight junction permeability barrier. J Cell Biol 136: 399-409, 1997. (Pubitemid 27063089)
16. Chlenski A, Ketels KV, Tsao MS, Talamonti MS, Anderson MR, Oyasu R and Scarpelli DG: Tight junction protein ZO-2 is differentially expressed in normal pancreatic ducts compared to human pancreatic adenocarcinoma. Int J Cancer 82: 137-144, 1999. (Pubitemid 29266119)
17. Balda MS and Matter K: Epithelial cell adhesion and the regulation of gene expression. Trends Cell Bio 13: 310-318, 2003. (Pubitemid 36638798)
18. Benedicto I, Molina-Jiménez F, Bartosch B, Cosset FL, Lavillette D, Prieto J, Moreno-Otero R, Valenzuela-Fernández A, Aldabe R, López-Cabrera M and Majano PL: Tight junction-associated protein occiudin is required for a post-binding step in hepatitis C entry and infection. J Viro doi: 10.1128/JVI.00038-09, 2009.
19. Boettner B and Van Aelst L: The role of Rho GTPases in disease development. Gene 286: 155-714, 2002.
20. Clark EA, Golub TR, Lander ES and Hynes RO: Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406: 532-535, 2000. (Pubitemid 30625739)
21. van Golen KL, Wu ZF, Qiao XT, Bao L and Merajver SD: RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells. Neoplasia 2: 418-425, 2000. (Pubitemid 32044787)
22. Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA and Merajver SD: Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am J Pathol 160: 579-584, 2002.
23. Kamai T, Tsujii T, Arai K, Takagi K, Asami H, Ito Y and Oshima H: Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 9: 2632-2641, 2003. (Pubitemid 36842107)
24. Pan Y, Bi F, Liu N, Xue Y, Yao X, Zheng Y and Fan D: Expression of seven main Rho family members in gastric carcinoma. Biochem Biophys Res Commun 315: 686-691, 2004. (Pubitemid 38229398)
25. Hopkins AM, Walsh SV, Verkade P, Boquet P and Nusrat A: Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function. J Cell Sci 116: 725-742, 2003. (Pubitemid 36231311)
26. Wojciak-Stothard B and Ridley AJ: Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol 39: 87-99, 2002.
27. Fujita H, Katoh H, Hasegawa H, Yasui H, Aoki J, Yamaguchi Y and Negishi M: Molecular decipherment of Rho effector pathways regulating tight-junction permeability. Biochem J 346: 617-622, 2000. (Pubitemid 30171021)
28. Du Pasquier L, Zucchetti I and De Santis R: Immunoglobulin superfamily receptors in protochordates: before RAG time. Immunol Rev 198: 233-248, 2004. (Pubitemid 38406947)